Skip to main content

Athersys, Inc

ATHXDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001368148

Athersys, Inc was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 21, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $1.18M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Athersys, Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of ATHX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders4643−3
Shares4.35M2.73M−1.62M (−37.3%)
Value$3.79M$1.18M−$2.61M (−68.9%)

New holders (5)

Institutions that held Athersys, Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ATHX in Q3 2023
InstitutionSharesValue% of portfolio
Citadel Advisors LLC40,783$17.6K0.00%
Virtu Financial LLC26,497$11.0K0.00%
XTX Topco Ltd17,373$7.51K0.00%
Macroview Investment Management LLC105$460.00%
Qube Research & Technologies Ltd1$00.00%

Sold out (8)

Institutions that held Athersys, Inc at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ATHX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Susquehanna Fundamental Investments, LLC49,849$43.4K
Price T Rowe Associates Inc42,376$37.0K
CIBC Asset Management Inc36,376$31.6K
Green Alpha Advisors, LLC21,334$18.6K
Pathstone Family Office, LLC13,016$11.3K
Two Sigma Securities, LLC11,473$9.98K
Arlington Partners LLC250$218
Sofos Investments, Inc.1–